Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Indian Immunologicals Limited, is an unlisted public company incorporated on 08 October, 1999. It is classified as a public limited company and is located in Rangareddi, Telangana. It's authorized share capital is INR 400.00 cr and the total paid-up capital is INR 54.00 cr.
Indian Immunologicals Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 14.81% over the previous year. At the same time, it's book networth has increased by 22.04%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
48.13%
99.59%
122.83%
40.06%
-23.63%
30.81%
0.13
11.17
9.76
10.95
13.97
-0.03
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(29)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
National Dairy Development Board
No. of Loans: 3
Total Amount : 175.2 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 120.0 cr
Kotak Mahindra Bank Limited
No. of Loans: 1
Total Amount : 40.0 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Agnihotra Dakshina Murty Chavali | 00374673 | 10 years |
| Director | Kinnera Bhagavatula | 01878144 | 10 years |
| Director | Meeneshkumar Champaklal Shah
Shareholder
|
03147155 | 3 years |
| Managing Director | Anand Kumar Kanakasapapathy
Shareholder
|
03268712 | 11 years |
| CS | Shuchi Sharma | <HIDDEN> | 7 years |
| Director | Devanand Chakkingal Pathayapura | 07773929 | 3 years |
| Director | Sanjay Madhav Mehendale | 08080775 | 7 years |
| Whole-time Director | Priyabrata Pattnaik | 09253601 | 3 years |
| Director | Rajeev Sivarama
Shareholder
|
09254521 | 3 years |
| CFO | Appalaraja Sekhar Ganasala
Shareholder
|
<HIDDEN> | 7 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| NATCO PHARMA LIMITED |
Active
|
35.8 Cr | 1 | Telangana |
| CAPSAVE FINANCE PRIVATE LIMITED |
Active
|
19.0 Cr | 1 | Maharashtra |
| KALYAN JEWELLERS INDIA LIMITED |
Active
|
1,031.2 Cr | 1 | Kerala |
| POKARNA ENGINEERED STONE LIMITED |
Active
|
4.2 Cr | 1 | Telangana |
| POKARNA LIMITED |
Active
|
6.2 Cr | 1 | Telangana |
| TELANGANA INDUSTRIAL HEALTH CLINIC LIMITED |
Active
|
10.0 Cr | 1 | Telangana |
| MIDGARD TECHNOLOGIES PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Telangana |
| NICDIT KRISHNAPATNAM INDUSTRIAL CITY DEVELOPMENT LIMITED |
Active
|
1,067.7 Cr | 1 | Andhra Pradesh |
| MOTHER DAIRY FRUIT AND VEGETABLE PRIVATE LIMITED |
Active
|
250.0 Cr | 4 | Delhi |
| SAFAL NATIONAL EXCHANGE OF INDIA LIMITED |
Amalgamated
|
24.0 Cr | 1 | Delhi |
| NDDB DAIRY SERVICES |
Active
|
200.0 Cr | 2 | Delhi |
| VIDYA DAIRY |
Active
|
0.0 | 1 | Gujarat |
| NORTH EAST DAIRY AND FOODS LIMITED |
Active
|
10.0 Cr | 2 | Assam |
| NDDB CALF LIMITED |
Active
|
75.0 Cr | 1 | Gujarat |
| NDDB MRIDA LIMITED |
Active
|
9.5 Cr | 1 | Gujarat |
| IDMC LIMITED |
Active
|
12.1 Cr | 2 | Gujarat |
| SHREEJA MAHILA MILK PRODUCER COMPANY LIMITED |
Active
|
32.8 Cr | 1 | Andhra Pradesh |
| KASHEE MILK PRODUCER COMPANY LIMITED |
Active
|
1.4 Cr | 1 | Uttar Pradesh |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Pristine Biologicals (NZ) Limited | New Zealand | - | - |
The incorporation date of INDIAN IMMUNOLOGICALS LIMITED is 08 October, 1999
The authorized share capital of INDIAN IMMUNOLOGICALS LIMITED is INR ₹ 400.0 Cr.
The paid-up capital of INDIAN IMMUNOLOGICALS LIMITED is INR ₹ 54.0 Cr.
The registered address of INDIAN IMMUNOLOGICALS LIMITED is Indian Immunologicals Limited, Road No. 44, Jubilee Hills NA Hyderabad Rangareddi Telangana - 500033
The CIN number of INDIAN IMMUNOLOGICALS LIMITED is U72200TG1999PLC032666.
Expand
Delete
Collapse
See
details
